Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1992 1
1996 1
1998 2
1999 3
2000 6
2001 1
2002 2
2003 3
2004 2
2005 2
2006 3
2007 5
2009 3
2010 4
2011 6
2012 5
2013 2
2014 2
2015 1
2016 3
2017 4
2018 1
2019 2
2020 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.
Pascual J, Berger SP, Witzke O, Tedesco H, Mulgaonkar S, Qazi Y, Chadban S, Oppenheimer F, Sommerer C, Oberbauer R, Watarai Y, Legendre C, Citterio F, Henry M, Srinivas TR, Luo WL, Marti A, Bernhardt P, Vincenti F; TRANSFORM Investigators. Pascual J, et al. Among authors: mulgaonkar s. J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study.
Berger SP, Sommerer C, Witzke O, Tedesco H, Chadban S, Mulgaonkar S, Qazi Y, de Fijter JW, Oppenheimer F, Cruzado JM, Watarai Y, Massari P, Legendre C, Citterio F, Henry M, Srinivas TR, Vincenti F, Gutierrez MPH, Marti AM, Bernhardt P, Pascual J; TRANSFORM investigators. Berger SP, et al. Among authors: mulgaonkar s. Am J Transplant. 2019 Nov;19(11):3018-3034. doi: 10.1111/ajt.15480. Epub 2019 Jul 1. Am J Transplant. 2019. PMID: 31152476 Free article. Clinical Trial.
Alemtuzumab induction in renal transplantation.
Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, Croy R, Holman J; INTAC Study Group. Hanaway MJ, et al. Among authors: mulgaonkar s. N Engl J Med. 2011 May 19;364(20):1909-19. doi: 10.1056/NEJMoa1009546. N Engl J Med. 2011. PMID: 21591943 Free article. Clinical Trial.
Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial.
Weir MR, Pearson TC, Patel A, Peddi VR, Kalil R, Scandling J, Chan L, Baliga P, Melton L, Mulgaonkar S, Waid T, Schaefer H, Youssef N, Anandagoda L, McCollum D, Lawson S, Gordon R. Weir MR, et al. Among authors: mulgaonkar s. Transplantation. 2017 Jan;101(1):157-165. doi: 10.1097/TP.0000000000001098. Transplantation. 2017. PMID: 26950714
Chain transplantation: initial experience of a large multicenter program.
Melcher ML, Leeser DB, Gritsch HA, Milner J, Kapur S, Busque S, Roberts JP, Katznelson S, Bry W, Yang H, Lu A, Mulgaonkar S, Danovitch GM, Hil G, Veale JL. Melcher ML, et al. Among authors: mulgaonkar s. Am J Transplant. 2012 Sep;12(9):2429-36. doi: 10.1111/j.1600-6143.2012.04156.x. Epub 2012 Jul 19. Am J Transplant. 2012. PMID: 22812922 Free article.
Unmasking of primary hyperaldosteronism by renal transplantation.
Kaplan B, Cheema A, Friedman G, Shah N, Bonomini L, Mulgaonkar S, Nambi S, De Franco P. Kaplan B, et al. Among authors: mulgaonkar s. Transplantation. 2000 Apr 15;69(7):1503-5. doi: 10.1097/00007890-200004150-00050. Transplantation. 2000. PMID: 10798779
60 results